The selloff looks dramatic until you realize this stock is still up 31% in two months and sitting at a 73% IV that's screaming 'overreaction tax.' Yesterday's -7% plunge is testing the first meaningful support level around $25. 50, but with a 55% trend score and no reversal signal, this feels more like profit-taking in a parabolic move than a true breakdown.

The chart obsessive in me sees that $25 level as a psychological floor—it's held twice in the last month—but the risk-first skeptic is shouting that a 73% IV for a mature tech name like HPQ is pricing in Armageddon, not a healthy pullback. Here's why that matters: when IV is this elevated, you're selling expensive insurance, but you're also selling into a stock that's shown it can gap down hard. The probability quant would note the expected move over the next 35 days is roughly ±$9.

50—that's huge—meaning a 3-7% OTM put could easily get run over. For a credit put spread, we'd need to sell a put around $24. 25 (5% OTM) and buy the $22.

50 for protection, netting maybe $0. 85 on a $1. 75 wide spread.

That's a credit/width ratio of 0. 49, which passes the math test, but the max loss of $90 per contract feels like picking up dimes in front of a steamroller that's already moving. The patient structure teacher would say the setup isn't clean: we're trying to catch a falling knife without confirmation of a floor, and the sector context (tech getting whacked) adds macro risk.

My blended take: the premium is juicy, but the risk of continued momentum selling outweighs the reward. We need to see if $25 holds for a few sessions. If you're itching to trade this, wait for a daily close above $26 to signal some stabilization—otherwise, this is a classic 'volatility trap.'